A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems
暂无分享,去创建一个
Česlovas Venclovas | Gintautas Tamulaitis | Virginijus Siksnys | Č. Venclovas | V. Šikšnys | G. Tamulaitis | Migle Kazlauskiene | Georgij Kostiuk | Migle Kazlauskiene | Georgij Kostiuk
[1] M. Jinek,et al. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6 , 2016, RNA.
[2] W. Guo,et al. Crystal structures of CRISPR-associated Csx3 reveal a manganese-dependent deadenylation exoribonuclease , 2015, RNA biology.
[3] Luciano A. Marraffini,et al. Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity , 2016, Cell.
[4] Johannes Söding,et al. The HHpred interactive server for protein homology detection and structure prediction , 2005, Nucleic Acids Res..
[5] Jie Zhou,et al. Cyclic dinucleotide (c-di-GMP, c-di-AMP, and cGAMP) signalings have come of age to be inhibited by small molecules. , 2016, Chemical communications.
[6] Scott Bailey,et al. RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex. , 2016, Genes & development.
[7] Česlovas Venclovas,et al. Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition. , 2016, Molecular cell.
[8] U. Baumann,et al. An efficient one-step site-directed and site-saturation mutagenesis protocol. , 2004, Nucleic acids research.
[9] B. Oh,et al. Crystal structure and nucleic acid‐binding activity of the CRISPR‐associated protein Csx1 of Pyrococcus furiosus , 2013, Proteins.
[10] R. Terns,et al. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease , 2016, RNA.
[11] Alan R. Davidson,et al. Multiple mechanisms for CRISPR–Cas inhibition by anti-CRISPR proteins , 2015, Nature.
[12] E. Koonin,et al. Coupling immunity and programmed cell suicide in prokaryotes: Life‐or‐death choices , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.
[13] C. Lawrence,et al. Recognition of a pseudo-symmetric RNA tetranucleotide by Csx3, a new member of the CRISPR associated Rossmann fold superfamily , 2016, RNA biology.
[14] Česlovas Venclovas,et al. Type III CRISPR-Cas Immunity: Major Differences Brushed Aside. , 2017, Trends in microbiology.
[15] M. F. White,et al. CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems , 2014, Front. Genet..
[16] T. Osawa,et al. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex. , 2013, Journal of molecular biology.
[17] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[18] Y. Tong,et al. An easy-to-use site-directed mutagenesis method with a designed restriction site for convenient and reliable mutant screening , 2009, Journal of Zhejiang University SCIENCE B.
[19] Joshua R. Elmore,et al. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system , 2016, Genes & development.
[20] Y. Chernajovsky,et al. An interferon-induced phosphodiesterase degrading (2'-5') oligoisoadenylate and the C-C-A terminus of tRNA. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Terns,et al. Structure of the Cmr2 subunit of the CRISPR-Cas RNA silencing complex. , 2012, Structure.
[22] Aurélien Grosdidier,et al. SwissDock, a protein-small molecule docking web service based on EADock DSS , 2011, Nucleic Acids Res..
[23] Eric S. Lander,et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector , 2016, Science.
[24] H. Yoshino,et al. Substrate Specificity of Nuclease P1 , 1974 .
[25] Luciano A. Marraffini,et al. Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity , 2015, Cell.
[26] Ceslovas Venclovas,et al. Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. , 2014, Molecular cell.
[27] J. Doudna,et al. RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System , 2017, PloS one.
[28] Koichi Yoshioka,et al. KyPlot – A User-oriented Tool for Statistical Data Analysis and Visualization , 2002, Comput. Stat..
[29] E. Koonin,et al. Comprehensive analysis of the HEPN superfamily: identification of novel roles in intra-genomic conflicts, defense, pathogenesis and RNA processing , 2013, Biology Direct.
[30] K. Ye,et al. Crystal structure of Cmr2 suggests a nucleotide cyclase‐related enzyme in type III CRISPR‐Cas systems , 2012, FEBS letters.
[31] Eugene V Koonin,et al. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems , 2011, Biology Direct.
[32] R. Silverman,et al. A scientific journey through the 2-5A/RNase L system. , 2007, Cytokine & growth factor reviews.
[33] Yang Zhang,et al. Atomic-level protein structure refinement using fragment-guided molecular dynamics conformation sampling. , 2011, Structure.
[34] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[35] J. Tainer,et al. The structure of the CRISPR-associated protein Csa3 provides insight into the regulation of the CRISPR/Cas system. , 2011, Journal of molecular biology.
[36] Yue Zheng,et al. Cyclic Dinucleotide (c‐di‐GMP, c‐di‐AMP, and cGAMP) Signalings Have Come of Age to Be Inhibited by Small Molecules , 2016 .
[37] Johannes Söding,et al. Protein homology detection by HMM?CHMM comparison , 2005, Bioinform..
[38] L. Aravind,et al. Comparative genomic analyses reveal a vast, novel network of nucleotide-centric systems in biological conflicts, immunity and signaling , 2015, Nucleic acids research.
[39] Eugene V Koonin,et al. The basic building blocks and evolution of CRISPR-CAS systems. , 2013, Biochemical Society transactions.